This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
By its name and nature, heart failure doesn’t have a good outlook. The progressive disease is diagnosed when the heart is no longer able to pump blood and oxygen throughout the body as well as it should, limiting daily activities and lifespan. Medications have improved at easing its symptoms, including obesity drugs that appear to work by reducing weight and fat, but researchers have long sought a more direct repair of heart failure’s damage.
As interview season wraps up, medical students across the country are preparing their rank lists for the upcoming Match. EM Match Advice podcast host, Dr. Sara Krzyzaniak (Stanford EM Program Director) recently sat down with Dr. Melissa Parsons (University of Florida College of Medicine – Jacksonville EM Program Director), to discuss the match process from both program and applicant perspectives.
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, potentially limiting patients’ ability to access it.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
WASHINGTON — A new memo from the White House budget office indicates that Medicaid payments should not be affected by a pause on some federal grants. States, though, on Tuesday were reporting difficulties accessing Medicaid payment portals. “Mandatory programs like Medicaid and SNAP will continue without pause,” the White House Office of Management and Budget stated in a two-page memo sent to Capitol Hill Tuesday.
The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat neurological conditions like Huntington’s.
My son was 5 years old when he climbed out of bed and landed on the floor. He was always a teaser. “C’mon, silly,” I said. “Time to get ready for school.” “Mommy,” Aaron said, very puzzled. “I can’t feel my legs.
As changes to the U.S. regulatory foundation take hold, pharmas need to change their strategies to keep innovation — and the bottom line — above the surface.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
A focus on using community pharmacies to relieve the burden on primary care could lead to the 'unintended consequence' that pharmacists' unique medicines skills are not utilised, the Pharmacists' Defence Association (PDA) has warned. In a report reflecting on the first year of Pharmacy First in England, the PDA highlighted that providing more clinical services […] The post Focus on minor ailments risks 'underutilising' pharmacists' skills, warns PDA appeared first on The Pha
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful biotechs contend with a healthcare system that’s long favored opioids?
LONDON — People in England with sickle cell disease will now be able to access the world’s first CRISPR-based medicine under a pricing and reimbursement agreement reached between U.K. health officials and Vertex Pharmaceuticals. The deal is notable because the U.K.’s cost-effectiveness watchdog initially raised concerns about the durability of the treatment, called Casgevy, in a preliminary ruling last year, saying it wasn’t yet recommending the therapy.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
The clearance is a step forward in AstraZeneca and Daiichi Sankyo’s plan to position antibody-drug conjugates like Enhertu ahead of chemotherapy in a variety of tumors.
Earlier this month, a newer patient came in to see me for a check-up and discussion about her extremely high cholesterol level. In her late 50s with a family history of early-age heart attack, she was in a high-risk group for future stroke and coronary heart disease. When I suggested that a statin drug would help mitigate this risk, she replied with something I’m increasingly hearing from patients: “I’m really not a medicine person.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Its been a year of amazing achievements and significant progress, but Pharmacy First has really only just got started, says Shilpa Shah of Community Pharmacy North East London (CP NEL) A year on, and how are we doing with Pharmacy First? The answer is that its a mixed picture. Some surgeries have embraced this service […] The post How are we doing with Pharmacy First?
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Another busy day, so let’s get straight into the news.
Vertex Pharmaceuticals’ non-opioid pain medication is up for FDA approval this week. Other drugmakers have found safer alternatives to expand the pain management landscape.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharmacies are seeing 'double' the demand for Pharmacy First consultations on Sundays than would be expected in line with reduced opening hours, a new report from the Company Chemists' Association (CCA) has suggested. The CCA said a 'surprising volume' of weekend consultations demonstrated the value of access to the service out-of-hours. Today marks the one […] The post Weekend demand shows value of Pharmacy First access appeared first on The Pharmacist.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, today we look at RFK Jr.’s first day of confirmation hearings and the latest biotech news.
“Are you supportive of these onesies?” Sen. Bernie Sanders asked Kennedy, pointing to infant clothing stamped with anti-vaccine slogans — and more from yesterday’s confirmation hearing.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Community Pharmacy Contractual Framework negotiations have now begun for the 2024/25 and 2025/26 funding agreements, the government has announced. The government sent a letter to Community Pharmacy England (CPE) on Monday to signal the start of the negotiations, the Department of Health and Social Care (DHSC) said today. Minister of state for care Stephen Kinnock […] The post BREAKING: Pharmacy contract negotiations begin for 2024/25 and 2025/26 appeared first on The Pharmacist.
Curie.Bio, the biotech accelerator and investment firm started by Alexis Borisy and Zach Weinberg, has raised another $340 million to invest in startups. Borisy and Weinberg’s firm was created to upend the biotech financing model , offering both capital and expert assistance to founders seeking on option outside of traditional VC funding. The idea has resonated with venture capitalists — several of whom have invested in Curie.Bio — and startups.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
323 
Let's personalize your content